SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-006315
Filing Date
2021-01-29
Accepted
2021-01-29 20:02:05
Documents
1
Period of Report
2021-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4259
  Complete submission text file 0001209191-21-006315.txt   5728
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HARPOON THERAPEUTICS, INC. 4000 SHORELINE COURT, SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address
Wesche Holger (Reporting) CIK: 0001763592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 21573740